Video - Results from #20

Hot Topic QuickTakes VL

Search

Nurse Practitioners and Physician Assistants: The Future of Urology - Diane Newman Details Diane Newman, an adult nurse practitioner and a continence nurse specialist in urology, provides an expert lecture on the growing future of nurse practitioners and physician assistants specifically in the field of urology. Both nurse practitioners and physician assistants were rated in the 100 best jobs by the US News and World Report in 2019. Biographies: Diane K. Newman, DNP, ANP-BC, FAAN , Adju...
SPARTAN: A Study of Apalutamide in Men with M0 Castration-Resistant Prostate Cancer (M0 CRPC) - Alan Bryce Details (Length of Presentation and Discussion: 9 minutes) Alan Bryce provides an overview of results from SPARTAN: A Study of Apalutamide (ARN-509) in Men with Non-Metastatic Castration-resistant Prostate Cancer - and the subsequent FDA approval of apalutamide for treatment of men with M0 castration resistant prostate cancer ( M0 CRPC). The presentation includes a review of the data on the primary and se...
Radical Prostatectomy for Patients with Oligometastatic Prostate Cancer - Robert Hamilton Details Robert Hamilton, a Staff Urologic Oncologist from Princess Margaret Cancer Centre in Toronto, Canada discusses radical prostatectomy for patients with oligometastatic prostate cancer. He overviews the clinical and biological rationale for radical prostatectomy in the oligometastases setting and highlights the role of novel imaging. He reviews four major PET tracers receiving a lot of attention: PS...
Axumin™ (Fluciclovine F 18) Injection for PET Imaging of Recurrent Prostate Cancer - Phillip Koo Details In this 5 for 5 Hot Topics, Phillip Koo, MD. presents the clinical background of Axumin™ (Fluciclovine F 18) Injection for PET Imaging of Recurrent Prostate Cancer, the first FDA-approved F18 PET Imaging Agent indicated in for use in patients with suspected recurrent prostate cancer. Dr. Koo discusses its use for men with suspected prostate cancer recurrence based on elevated PSA levels following...